Suppr超能文献

SN6999与烷基化DNA的小沟结合:d(CGC[e6G]AATTCGCG)-SN6999复合物的分子结构

Minor groove binding of SN6999 to an alkylated DNA: molecular structure of d(CGC[e6G]AATTCGCG)-SN6999 complex.

作者信息

Gao Y G, Sriram M, Denny W A, Wang A H

机构信息

Division of Biophysics, University of Illinois at Urbana-Champaign 61801.

出版信息

Biochemistry. 1993 Sep 21;32(37):9639-48. doi: 10.1021/bi00088a016.

Abstract

The interaction between a potent synthetic antitumor and antiviral minor groove binding drug 1-methyl-4-[4-[4-(4-(1-methylquinolinium)amino)benzamido]anilino] pyridinium dichloride (SN6999) and an alkylated DNA d(CGC[e6G]AATTCGCG) dodecamer has been studied by X-ray crystallography. The complex forms a new crystal lattice in the space group P2(1)2(1)2(1) with unit cell dimensions of a = 28.48 A, b = 36.11 A, and c = 69.60 A. The structure has been solved by the molecular replacement method and refined to an R-factor of 17.0% at approximately 2.5 A resolution using 1618 reflections. In the complex, the SN6999 covers almost six base pairs in the narrow minor groove with the 1-methylquinolinium (Q) ring near T8-A17 and the 1-methylpyridinium (P) ring near the C3-G22 base pair. The central benzamido (BQ) and anilino (BP) rings are essentially coplanar, with the Q and P rings having large dihedral angles of 38 degrees and 39 degrees, respectively, to the plane of BQ/BP. There is only one direct hydrogen bond between the amide NH of SN6999 to T20O2 of DNA. The drug-DNA interaction is stabilized by stacking interaction of sugar oxygens from T20O4' to BQ and C21O4' to BP. There is charge-induced dipole interaction between the positively charged nitrogen atom of 1-methylquinolinium with C9O4' and that of 1-methylpyridinium with G22O4'. The crystal structure of the complex can be used to explain the NMR results. SN6999 lacks the crescent shape observed in other minor groove binding drugs and distorts the DNA duplex upon binding. The complex packs in the lattice using the G-N2:G-N3 interlocking base pairs at both ends of the helix. As in earlier cases, the two independent e6G:C base pairs adopt different base pairing schemes. The e6G16:C9 base pair adopts a previously observed bifurcated configuration involving three-centered hydrogen bonds and is similar to a Watson-Crick pairing. In contrast, the e6G4:C21 base pair adopts a novel "reverse wobble" configuration with C21 being pushed toward the major groove side. The ethyl group is in the proximal orientation (to N7) in both base pairs. Taken together with the observations found in the same DNA complexed to Hoechst 33258, Hoechst 33342, and retropsin from different crystal lattices, the results suggest that the e6G:C base pairing is weak and polymorphic when compared to a normal G:C base pair and the DNA duplex containing this lesion is readily distorted.

摘要

通过X射线晶体学研究了一种强效合成抗肿瘤和抗病毒小沟结合药物1-甲基-4-[4-[4-(4-(1-甲基喹啉鎓)氨基)苯甲酰胺基]苯胺基]吡啶二氯化物(SN6999)与烷基化DNA d(CGC[e6G]AATTCGCG)十二聚体之间的相互作用。该复合物在空间群P2(1)2(1)2(1)中形成新的晶格,晶胞尺寸为a = 28.48 Å,b = 36.11 Å,c = 69.60 Å。采用分子置换法解析了结构,并在约2.5 Å分辨率下使用1618个反射将其精修至R因子为17.0%。在复合物中,SN6999覆盖了狭窄小沟中近六个碱基对,1-甲基喹啉鎓(Q)环靠近T8-A17,1-甲基吡啶鎓(P)环靠近C3-G22碱基对。中央苯甲酰胺基(BQ)和苯胺基(BP)环基本共面,Q环和P环与BQ/BP平面的二面角分别为38度和39度。SN6999的酰胺NH与DNA的T20O2之间只有一个直接氢键。药物与DNA的相互作用通过从T20O4'到BQ以及C21O4'到BP的糖氧堆积相互作用得以稳定。1-甲基喹啉鎓带正电荷的氮原子与C9O4'之间以及1-甲基吡啶鎓与G22O4'之间存在电荷诱导偶极相互作用。该复合物的晶体结构可用于解释核磁共振结果。SN6999缺乏在其他小沟结合药物中观察到的月牙形,并且在结合时会扭曲DNA双链体。复合物在晶格中通过螺旋两端的G-N2:G-N3互锁碱基对堆积。与早期情况一样,两个独立的e6G:C碱基对采用不同的碱基配对方式。e6G16:C9碱基对采用先前观察到的涉及三中心氢键的分叉构型,类似于沃森-克里克配对。相比之下,e6G4:C21碱基对采用新颖的“反向摆动”构型,C21被推向大沟一侧。在两个碱基对中乙基都处于近端取向(相对于N7)。结合在不同晶格中与Hoechst 33258、Hoechst 33342和逆转蛋白酶复合的同一DNA中的观察结果,结果表明与正常G:C碱基对相比,e6G:C碱基配对较弱且具有多态性,并且含有这种损伤的DNA双链体容易扭曲。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验